N,O-Didesmethyltramadol
Metabolite of tramadol
| N,O-Didesmethyltramadol | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 36282-47-0 |
| PubChem | 3083540 |
| DrugBank | |
| ChemSpider | 2340865 |
| KEGG | |
N,O-Didesmethyltramadol is a metabolite of the opioid analgesic tramadol. It is formed in the body through the metabolic pathway involving the cytochrome P450 enzyme system. This compound is one of the active metabolites that contribute to the pharmacological effects of tramadol.
Chemical Structure and Properties[edit | edit source]
N,O-Didesmethyltramadol is characterized by the removal of two methyl groups from the parent compound, tramadol. The chemical structure consists of a cyclohexanol ring with a methoxyphenyl group and a dimethylamino group. The molecular formula is C13H19NO2, and it has a molecular weight of 221.3 g/mol.
Pharmacology[edit | edit source]
N,O-Didesmethyltramadol retains some of the analgesic properties of tramadol, although it is generally less potent. The compound acts on the central nervous system by binding to opioid receptors, primarily the mu-opioid receptor. It also inhibits the reuptake of serotonin and norepinephrine, contributing to its analgesic effects.
Metabolism[edit | edit source]
Tramadol is metabolized in the liver by the cytochrome P450 enzyme system, particularly by CYP2D6 and CYP3A4. N,O-Didesmethyltramadol is produced through the demethylation of tramadol, a process that involves the removal of methyl groups. This metabolite is further processed and eventually excreted in the urine.
Clinical Significance[edit | edit source]
The presence of N,O-Didesmethyltramadol in the body can influence the overall efficacy and side effect profile of tramadol. Variability in the metabolism of tramadol, due to genetic differences in cytochrome P450 enzymes, can lead to differences in the levels of this metabolite among individuals. This can affect both the therapeutic and adverse effects experienced by patients.
Related Compounds[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
